Hemoglobin and Iron Metabolism Practice Questions

Q: A child ingests paint chips and subsequently develops acute abdominal pain, paresthesias in the hands and legs, and weakness. Which enzyme is inhibited in this child?

ALA dehydratase. **Explanation:** The clinical presentation of abdominal pain, peripheral neuropathy (paresthesias and weakness), and a history of ingesting paint chips (a common source of lead in older buildings) is classic for **Lead Poisoning (Plumbism)**. **Why ALA Dehydratase is correct:** Lead is a heavy metal that inhibits heme synthesis by displacing zinc from the active sites of two key enzymes: **$\delta$-Aminolevulinic Acid (ALA) Dehydratase** and **Ferrochelatase**. * Inhibition of **ALA Dehydratase** leads to an accumulation of ALA in the blood and urine, which is neurotoxic and contributes to the abdominal pain and neurological symptoms. * Inhibition of **Ferrochelatase** prevents the incorporation of iron into protoporphyrin IX, leading to elevated erythrocyte protoporphyrin levels. **Why other options are incorrect:** * **A. ALA Synthase:** This is the rate-limiting enzyme of heme synthesis. It is inhibited by heme (feedback inhibition) and stimulated by drugs processed by the Cytochrome P450 system, but it is not a direct target of lead. * **B. Heme Oxygenase:** This enzyme is involved in heme **degradation** (converting heme to biliverdin), not synthesis. * **C. Coproporphyrinogen Oxidase:** This enzyme is inhibited in **Hereditary Coproporphyria**, an autosomal dominant porphyria, but is not the primary target in lead poisoning. **NEET-PG High-Yield Pearls:** * **Basophilic Stippling:** A characteristic finding on peripheral smear in lead poisoning due to the inhibition of pyrimidine 5'-nucleotidase, leading to ribosomal RNA degradation products. * **Burton’s Lines:** Bluish-purple lines on the gingival margins. * **Radiology:** "Lead lines" (hyperdense metaphyseal bands) may be seen on X-rays of long bones in children. * **Treatment:** Chelation therapy with **Succimer** (oral, first-line in kids), **CaEDTA**, or **Dimercaprol (BAL)**.

Q: Why do patients with sickle cell trait typically not experience manifestations similar to sickle cell disease?

50% HbS is required for the occurrence of sickling.. ### Explanation **1. Why Option A is Correct:** The primary pathophysiology of Sickle Cell Disease (SCD) is the polymerization of deoxygenated Hemoglobin S (HbS). In **Sickle Cell Trait (HbAS)**, the concentration of HbS is typically around **35–45%**, while HbA makes up the remaining 55–60%. For significant sickling to occur under physiological conditions, a threshold of **at least 50% HbS** is generally required. Because the HbS concentration in trait patients remains below this critical threshold, the red blood cells do not sickle under normal oxygen tension, leaving the patient asymptomatic. **2. Analysis of Incorrect Options:** * **Option B:** While HbA is present, it doesn't "prevent" sickling by its mere presence; rather, it dilutes the HbS concentration below the required threshold for polymerization. * **Option C:** This is factually incorrect. In sickle cell trait, less than 1% of cells are sickled in vivo under normal conditions. * **Option D:** HbA is relatively "inert" regarding polymerization. It does not actively inhibit HbS polymerization as effectively as **HbF (Fetal Hemoglobin)** does. HbF is a potent inhibitor of polymerization, which is why newborns with SCD are asymptomatic until HbF levels drop. **3. Clinical Pearls for NEET-PG:** * **The "Protective" Effect:** HbA2 and HbF are potent inhibitors of HbS polymerization; HbA is a weak inhibitor. * **Conditions for Sickling in Trait:** Patients with Sickle Cell Trait may experience sickling only under **extreme conditions** (severe hypoxia, acidosis, or extreme dehydration), such as unpressurized aircraft or high-altitude climbing. * **Renal Manifestation:** The most common clinical manifestation in Sickle Cell Trait is **Isosthenuria** (inability to concentrate urine) and painless **hematuria** due to micro-sickling in the hypertonic, hypoxic renal medulla. * **Electrophoresis:** HbAS shows HbA > HbS; HbSS shows no HbA.

Q: Hepcidin is associated with which molecule?

Iron. **Explanation:** **Hepcidin** is the master regulator of iron homeostasis in the human body. It is a peptide hormone synthesized primarily by the **liver** in response to high iron levels or inflammatory cytokines (like IL-6). **Why Iron is the Correct Answer:** Hepcidin controls iron levels by binding to **Ferroportin**, the only known cellular iron exporter found on the surface of enterocytes, macrophages, and hepatocytes. When Hepcidin binds to Ferroportin, it induces its internalization and degradation. This results in: 1. **Decreased intestinal iron absorption** (iron stays trapped in enterocytes). 2. **Decreased iron release** from macrophages (recycling of senescent RBCs). Consequently, high Hepcidin levels lead to low serum iron, while Hepcidin deficiency leads to iron overload (e.g., Hemochromatosis). **Why Other Options are Incorrect:** * **Copper:** Regulated primarily by **Ceruloplasmin** (transport) and **ATP7B** (excretion). Deficiency leads to Menkes disease; toxicity leads to Wilson disease. * **Selenium:** A cofactor for **Glutathione Peroxidase**. It is not regulated by Hepcidin. * **Fluorine:** Primarily involved in dental and bone health (fluoroapatite formation). It is not linked to Hepcidin. **High-Yield Clinical Pearls for NEET-PG:** * **Anemia of Chronic Disease (ACD):** Inflammatory states (IL-6) increase Hepcidin, causing iron to be "locked" in macrophages. This leads to low serum iron despite normal/high ferritin. * **Hereditary Hemochromatosis:** Most commonly caused by mutations in the **HFE gene**, leading to inappropriately low Hepcidin levels and systemic iron overload. * **Stimuli:** Hepcidin is **increased** by iron overload and inflammation; it is **decreased** by hypoxia and increased erythropoietic activity.

Q: 2,3 DPG binds to __________ site of Hb and __________ release of O2

One, increase. **Explanation:** **1. Why Option A is Correct:** 2,3-Bisphosphoglycerate (2,3-DPG) is a highly anionic molecule that binds to a **single** central cavity (one site) located between the two beta-globin chains of the hemoglobin tetramer. This binding occurs specifically in the **T-state (Tense state)** or deoxygenated form. 2,3-DPG stabilizes the T-state by forming salt bridges, which reduces hemoglobin's affinity for oxygen. This shifts the oxygen-dissociation curve to the **right**, thereby **increasing the release of O2** to the peripheral tissues. **2. Why Other Options are Incorrect:** * **Options B & D (Four sites):** Hemoglobin has four binding sites for oxygen (one per heme group), but it only has **one** regulatory binding site for 2,3-DPG. * **Options C & D (Decrease release):** Decreasing the release of O2 would mean an increase in O2 affinity (Left shift). 2,3-DPG does the opposite; a decrease in 2,3-DPG (as seen in stored blood) would decrease O2 release. **3. Clinical Pearls for NEET-PG:** * **Fetal Hemoglobin (HbF):** HbF has a lower affinity for 2,3-DPG because its gamma chains have **serine** instead of histidine at position 143. This results in a higher O2 affinity, allowing the fetus to "pull" oxygen from maternal blood. * **Adaptation to Altitude:** Chronic hypoxia at high altitudes leads to an **increase** in 2,3-DPG levels to facilitate better oxygen unloading at tissues. * **Stored Blood:** Levels of 2,3-DPG drop in stored blood. Transfusing large amounts of "old" blood can temporarily impair oxygen delivery to tissues until the recipient's body regenerates 2,3-DPG.

Q: One mole of myoglobin binds to how many moles of oxygen?

1. ### Explanation **Correct Option: A (1)** Myoglobin is a monomeric hemeprotein found primarily in skeletal and cardiac muscle. Structurally, it consists of a single polypeptide chain (globin) associated with a single heme group. Since one heme group contains one ferrous iron ($Fe^{2+}$) atom capable of binding to one molecule of oxygen ($O_2$), **one mole of myoglobin binds to exactly one mole of oxygen.** **Analysis of Incorrect Options:** * **Option B (2):** This is incorrect as there is no physiological hemoglobin or myoglobin variant that binds specifically to two moles of oxygen per mole of protein. * **Option C (4):** This describes **Hemoglobin (HbA)**. Hemoglobin is a tetramer consisting of four polypeptide chains, each with its own heme group. Therefore, one mole of hemoglobin binds to four moles of oxygen. **High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Dissociation Curve (ODC):** Myoglobin exhibits a **hyperbolic** ODC, reflecting its high affinity for oxygen even at low partial pressures. In contrast, Hemoglobin exhibits a **sigmoidal** curve due to cooperativity. * **Function:** Myoglobin acts as an oxygen storage unit in muscles, releasing $O_2$ only during severe hypoxia or intense muscular contraction. It does not show the Bohr effect or sensitivity to 2,3-BPG. * **Clinical Marker:** Myoglobin is the **earliest cardiac marker** to rise following a Myocardial Infarction (within 1–3 hours), though it is not specific to cardiac muscle. * **Renal Impact:** In rhabdomyolysis, massive release of myoglobin into the blood (myoglobinuria) can lead to acute tubular necrosis and renal failure.

Q: What is the most useful method for estimating the total iron content of blood?

Ferritin. ### Explanation **Correct Option: A. Ferritin** Ferritin is the primary intracellular storage protein for iron. While most ferritin is found inside cells (liver, spleen, and bone marrow), a small amount circulates in the serum. This serum ferritin level is directly proportional to the body's total iron stores. In clinical practice, **Serum Ferritin** is considered the most sensitive and specific laboratory test for diagnosing iron deficiency anemia, as a low level is pathognomonic for depleted iron stores. **Analysis of Incorrect Options:** * **B. Transferrin:** This is the transport protein for iron in the plasma. While it indicates how much iron is being moved, it does not reflect total storage. In iron deficiency, transferrin levels (and Total Iron Binding Capacity - TIBC) actually increase as a compensatory mechanism. * **C. Erythropoietin:** This is a glycoprotein hormone produced by the kidneys that stimulates red blood cell production (erythropoiesis). It does not measure or store iron. * **D. Lactoferrin:** This is an iron-binding protein found primarily in secretory fluids (milk, saliva, tears) and neutrophil granules. Its primary role is antimicrobial (sequestering iron from bacteria) rather than serving as a marker for systemic iron stores. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** Bone marrow aspiration (Prussian blue staining) is the absolute gold standard for assessing iron stores, but **Serum Ferritin** is the most useful non-invasive biochemical test. * **Acute Phase Reactant:** Ferritin is an acute-phase reactant. Its levels can be falsely elevated in inflammation, malignancy, or liver disease, even if iron stores are low. * **Hemosiderin:** This is another storage form of iron, typically found in cases of iron overload; it is less readily available than ferritin.

Q: Bioavailability of non-heme iron is low compared to heme iron because:

Phytates inhibit absorption.. ### Explanation **1. Why the Correct Answer is Right:** Iron exists in two dietary forms: **Heme iron** (found in animal sources like meat) and **Non-heme iron** (found in plant sources like cereals and legumes). Heme iron is absorbed intact via specific transporters (HCP-1) and is highly bioavailable (15–35%). In contrast, non-heme iron (mostly in the ferric $Fe^{3+}$ state) must be reduced to the ferrous $Fe^{2+}$ state to be absorbed via DMT-1. The bioavailability of non-heme iron is significantly lower (2–20%) because it is highly sensitive to **dietary inhibitors**. **Phytates** (found in whole grains and nuts), **oxalates**, **polyphenols/tannins** (in tea/coffee), and **phosphates** bind to non-heme iron in the alkaline environment of the small intestine, forming insoluble complexes that cannot be absorbed. **2. Analysis of Incorrect Options:** * **Option A (Micronutrients):** While some micronutrients (like Copper) are essential for iron metabolism (e.g., Ceruloplasmin), they do not explain the *low* bioavailability compared to heme iron. * **Option C & D (Acids and Vitamin C):** These actually **increase** non-heme iron absorption. Gastric acid and Vitamin C (Ascorbic acid) act as reducing agents, converting $Fe^{3+}$ to $Fe^{2+}$ and maintaining its solubility. Therefore, they improve bioavailability rather than lowering it. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Meat Factor":** Small amounts of meat can enhance the absorption of non-heme iron when consumed together. * **Hepcidin:** The master regulator of iron; it degrades Ferroportin, thereby decreasing iron release into the plasma. * **Storage:** Iron is stored as **Ferritin** (soluble) and **Hemosiderin** (insoluble). * **Transport:** Iron is transported in the blood by **Transferrin** in the $Fe^{3+}$ state.

Q: What is seen as iron dispersed in the cytoplasm when observed under an electron microscope?

Apoferritin. **Explanation:** **1. Why Apoferritin is correct:** Iron is stored within cells in two primary forms: Ferritin and Hemosiderin. **Apoferritin** is the protein shell (devoid of iron) that combines with ferric iron to form Ferritin. Under an **electron microscope**, apoferritin and individual ferritin molecules appear as fine, electron-dense particles **dispersed throughout the cytoplasm**. When iron levels are low or during the initial stages of storage, the protein shells (apoferritin) are synthesized to sequester free iron, preventing oxidative damage. **2. Why the other options are incorrect:** * **Transferrin:** This is the primary **transport protein** for iron in the plasma, not a storage form in the cytoplasm. It carries iron between the site of absorption (intestine) and the site of utilization (bone marrow). * **Hemosiderin:** This is an insoluble, partially degraded form of ferritin. It appears as **large, irregular clumps** or aggregates rather than dispersed particles. While ferritin is visible via electron microscopy, hemosiderin is easily visualized under a light microscope using **Prussian Blue** stain. * **Ferritin:** While ferritin is the complete storage complex, the question specifically highlights the dispersed protein component/shell structure observed at the ultrastructural level. (Note: In many contexts, Ferritin and Apoferritin are used interchangeably, but Apoferritin specifically refers to the dispersed protein matrix). **3. NEET-PG High-Yield Pearls:** * **Storage Form:** Ferritin is the primary intracellular iron storage protein; its serum levels are the most sensitive indicator of **iron deficiency anemia**. * **Redox State:** Iron is absorbed in the **Ferrous (Fe2+)** state but stored and transported in the **Ferric (Fe3+)** state. * **Sideroblasts:** Erythroblasts containing ferritin granules are called sideroblasts; "Ringed sideroblasts" (iron in mitochondria) are a hallmark of **Sideroblastic Anemia**.

Q: Which of the following proteins possesses ferroxidase activity?

Ceruloplasmin. **Explanation:** **Ceruloplasmin** is the correct answer because it is a copper-containing α2-globulin that functions as a **ferroxidase enzyme**. In iron metabolism, iron is absorbed or released from stores in the ferrous state ($Fe^{2+}$). However, to be loaded onto its transport protein, transferrin, it must be oxidized to the ferric state ($Fe^{3+}$). Ceruloplasmin catalyzes this $Fe^{2+} \rightarrow Fe^{3+}$ conversion, facilitating iron transport and preventing the formation of toxic free radicals. **Analysis of Incorrect Options:** * **Albumin (A):** The most abundant plasma protein; it functions primarily in maintaining oncotic pressure and transporting various ligands (bilirubin, fatty acids, drugs), but lacks enzymatic ferroxidase activity. * **Haptoglobin (C):** An acute-phase reactant that binds **free hemoglobin** released during intravascular hemolysis to prevent iron loss via kidneys and protect against oxidative damage. * **Transferrin (D):** The primary **transport protein** for iron in the blood. It binds iron only in the ferric ($Fe^{3+}$) state but does not perform the oxidation itself. **High-Yield Clinical Pearls for NEET-PG:** * **Wilson’s Disease:** Characterized by a deficiency of ceruloplasmin due to defective copper incorporation and biliary excretion. Low serum ceruloplasmin is a key diagnostic marker. * **Hephaestin:** A homologous ferroxidase found on the basolateral membrane of enterocytes that works with ferroportin to export iron into the blood. * **Ferroxidase Deficiency:** Leads to iron accumulation in tissues (hemosiderosis) because iron cannot be mobilized from storage sites (macrophages/liver) onto transferrin.

Question 1

Which of the following factors stabilizes the T structure of hemoglobin?

Accepted Answer

2,3-BPG

Answer

Hydrophilic pockets

Answer

Pyrrole rings

Answer

Cationic ring

Question 2

A child ingests paint chips and subsequently develops acute abdominal pain, paresthesias in the hands and legs, and weakness. Which enzyme is inhibited in this child?

Accepted Answer

ALA dehydratase

Answer

ALA synthase

Answer

Heme oxygenase

Answer

Coproporphyrinogen oxidase

Question 3

Why do patients with sickle cell trait typically not experience manifestations similar to sickle cell disease?

Accepted Answer

50% HbS is required for the occurrence of sickling.

Answer

HbA prevents sickling.

Answer

50% sickles are present.

Answer

HbA prevents the polymerization of HbS.

Question 4

Hepcidin is associated with which molecule?

Accepted Answer

Iron

Answer

Copper

Answer

Selenium

Answer

Fluorine

Question 5

2,3 DPG binds to __________ site of Hb and __________ release of O2

Accepted Answer

One, increase

Answer

Four, increase

Answer

One, decrease

Answer

Four, decrease

Question 6

One mole of myoglobin binds to how many moles of oxygen?

Accepted Answer

1

Answer

2

Answer

4

Answer

None of the above

Question 7

What is the most useful method for estimating the total iron content of blood?

Accepted Answer

Ferritin

Answer

Transferrin

Answer

Erythropoietin

Answer

Lactoferrin

Question 8

Bioavailability of non-heme iron is low compared to heme iron because:

Accepted Answer

Phytates inhibit absorption.

Answer

Micronutrients enhance absorption.

Answer

Acids enhance absorption.

Answer

Vitamin C enhances absorption.

Question 9

What is seen as iron dispersed in the cytoplasm when observed under an electron microscope?

Accepted Answer

Apoferritin

Answer

Transferritin

Answer

Hemosiderin

Answer

Ferritin

Question 10

Which of the following proteins possesses ferroxidase activity?

Accepted Answer

Ceruloplasmin

Answer

Albumin

Answer

Haptoglobin

Answer

Transferrin

Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?